Last quarter (Q4 2022), Bio-Gene Technology Ltd.'s total revenue was AU$―, a decrease of ― from previous quarter. In Q4, Bio-Gene Technology Ltd.'s net income was AU$―. See Bio-Gene Technology Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 22	Jun 21	Jun 20	Jun 19
Total Revenue	-	AU$ 879.78K	AU$ 573.12K	AU$ 907.58K	AU$ 508.76K
Cost of Revenue	-	-	-	-	-
Gross Profit	-	AU$ 879.78K	AU$ 573.12K	AU$ 907.58K	AU$ 508.76K
Operating Expense	-	AU$ 3.85M	AU$ 3.04M	AU$ 3.07M	AU$ 2.70M
Operating Income	-	AU$ -2.97M	AU$ -2.47M	AU$ -2.16M	AU$ -2.19M
Net Non Operating Interest Income Expense	-	AU$ 52.86K	AU$ 37.78K	AU$ 63.25K	AU$ 135.85K
Other Income Expense	-	AU$ 6.48K	AU$ 30.97K	AU$ 164.55K	AU$ 2.90K
Pretax Income	-	AU$ -2.91M	AU$ -2.40M	AU$ -1.93M	AU$ -2.06M
Tax Provision	-	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	-	AU$ -2.91M	AU$ -2.40M	AU$ -1.93M	AU$ -2.06M
Basic EPS	-	AU$ -0.02	AU$ -0.02	AU$ -0.02	AU$ -0.02
Diluted EPS	-	AU$ -0.02	AU$ -0.02	AU$ -0.02	AU$ -0.02
Basic Average Shares	-	AU$ 153.34M	AU$ 137.23M	AU$ 119.37M	AU$ 117.75M
Diluted Average Shares	-	AU$ 153.34M	AU$ 137.23M	AU$ 119.37M	AU$ 117.75M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	-	-	-	-	-
Net Income From Continuing And Discontinued Operation	-	AU$ -2.91M	AU$ -2.40M	AU$ -1.93M	AU$ -2.06M
Normalized Income	-	AU$ -2.91M	AU$ -2.40M	AU$ -1.93M	AU$ -2.06M
Interest Expense	-	-	-	-	-
EBIT	-	AU$ -2.97M	AU$ -2.47M	AU$ -2.16M	AU$ -2.19M
EBITDA	-	AU$ -2.93M	AU$ -2.41M	AU$ -2.10M	AU$ -2.15M

Currency in AUD

Bio-Gene Technology Ltd. Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing